2001
DOI: 10.1159/000055690
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Mutations in Argentine Retinoblastoma Patients by Segregation of Polymorphisms, Exon Analysis and Cytogenetic Test

Abstract: The aim of this study was to detect chromosomal and molecular abnormalities in 16 Argentine families with retinoblastoma (RB). Chromosomes were analyzed by G-banding, DNA from leukocytes and tumors was studied by segregation of polymorphisms within RB gene (RB1) and the DNA from chorionic villus by sequencing. The karyotype of an Rb236 bilateral patient with dismorphic signs revealed a deletion in 13q13–21. Polymorphism and exon analyses showed a deletion in the 3′ end of RB1 in an Rb72 patient. The mutant RB1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
2

Year Published

2005
2005
2013
2013

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 7 publications
0
3
0
2
Order By: Relevance
“…The deoxyribonucleic acid (DNA) was obtained from peripheral blood leukocytes using the cetyltrimethylammonium bromide (CTAB) method, and from paraffin-embedded tumors by treatment with proteinase K. 9 Segregation analysis of six polymorphic loci within RB1 gene included: (i) three intragenic restriction fragment length polymorphisms (RFLPs): BamHI, XbaI and Tth111I (introns 1, 17 and 24), and (ii) three microsatellites: RBi2, RBi4 and RB1.20 (introns 2, 4 and 20). 10,11 The RFLPs amplified fragments were digested with the appropriate restriction enzyme and visualized in a 2% agarose gel by etidium bromide staining.…”
Section: Dna Isolation and Genotyping Of Polymorphic Locimentioning
confidence: 99%
See 1 more Smart Citation
“…The deoxyribonucleic acid (DNA) was obtained from peripheral blood leukocytes using the cetyltrimethylammonium bromide (CTAB) method, and from paraffin-embedded tumors by treatment with proteinase K. 9 Segregation analysis of six polymorphic loci within RB1 gene included: (i) three intragenic restriction fragment length polymorphisms (RFLPs): BamHI, XbaI and Tth111I (introns 1, 17 and 24), and (ii) three microsatellites: RBi2, RBi4 and RB1.20 (introns 2, 4 and 20). 10,11 The RFLPs amplified fragments were digested with the appropriate restriction enzyme and visualized in a 2% agarose gel by etidium bromide staining.…”
Section: Dna Isolation and Genotyping Of Polymorphic Locimentioning
confidence: 99%
“…Some of these results were already published. 9,10,12,13 Mutations were widely distributed throughout the RB1 gene and no hot spots were found. Most of the mutations had occurred de novo and differ from one patient to another.…”
Section: Mutational Analysismentioning
confidence: 99%
“…El análisis molecular fue informativo en 18 familias de las 34 incluidas en el estudio (53%) (tabla I), el 56% con Rb bilateral y el 44% con Rb unilateral (10)(11)(12)(13)(14). En 15 de ellas fue posible identificar si el alelo mutado era el paterno (en 6) o el materno (en 9).…”
Section: Resultsunclassified
“…Todos los casos fueron esporádicos, excepto la familia 1, que presentó padre (1) e hija (1´) con Rb. En total, se analizaron 130 muestras de ADN de leucocitos de sangre periférica, tumores y vellosidades coriónicas, por ensayos de Biología Molecular indirectos y directos como Southern blot (10), segregación de polimorfismos (11)(12)(13), PCR-heteroduplex y secuenciación (10,14) …”
Section: Sujetos Materials Y Métodosunclassified
“…Inactivation of both copies of the RB1 gene results in retinoblastoma [Knudson, 1971]. The spectrum of causative mutations ranges from large deletions to single base substitutions, with over 400 mutations in the RB1 gene having been reported to date [Alonso et al, 2001;Ata-ur-Rasheed et al, 2002;Blanquet et al, 1993Blanquet et al, , 1994Blanquet et al, , 1995Cowell and Cragg, 1996;Cowell et al, 1994;Dalamon et al, 2001;Houdayer et al, 2004;Jakubowska et al, 2001;Kiran et al, 2003;Kloss et al, 1991;Kumaramanickavel et al, 2003;Liu et al, 1995;Lohmann et al, 1992Lohmann et al, , 1994aLohmann et al, , 1994bLohmann et al, , 1996Lohmann et al, , 1997Richter et al, 2003;Yilmaz et al, 1998] (www.d-lohmann.de/Rb/mutations.html). The majority of these mutations disrupt protein function, i.e., nonsense and frameshift mutations, which account for about 76% of the mutations, followed by splice site mutations (15%), missense mutations (6%), in-frame deletions (2%), and mutations in the promoter region (1%).…”
Section: Introductionmentioning
confidence: 99%